167263-10-7Relevant articles and documents
NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS
-
Page/Page column 85, (2020/05/12)
Provided is a compound of formula I, their synthesis and their use for treating a SHP2 mediated disorder. More particularly, provided is a pharmaceutical composition comprising the said compound.
THERAPEUTIC COMPOUNDS AND COMPOSITIONS
-
Page/Page column 191, (2014/09/29)
Compounds of general formula (I) and compositions comprising compounds of general formula I that modulate pyruvate kinase are described herein. Also described herein are methods of using the compounds that modulate pyruvate kinase in the treatment of diseases.
THERAPEUTIC COMPOUNDS AND COMPOSITIONS
-
Page/Page column 204; 205, (2014/09/29)
Compounds of general formula (I) and compositions comprising compounds of general formula (I) that modulate pyruvate kinase are described herein. Also described herein are methods of using the compounds that modulate pyruvate kinase in the treatment of diseases.